Clinical Trial Detail

NCT ID NCT01386385
Title Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Paclitaxel

Carboplatin + Etoposide + Veliparib

Age Groups: adult

No variant requirements are available.